Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (4)
  • 2024 (4)
  • 2023 (12)
  • 2022 (13)
  • 2021 (13)
  • 2020 (3)
  • 2019 (3)
  • 2018 (1)

Subject

  • Drug Trafficking (428)
  • Synthetic drugs (204)
  • Guns/Weapons (108)
  • Fake Pills (89)
  • Seizures (Drugs/Property) (83)
  • OCDETF/Task Force (78)
  • Overdose (71)
  • Guilty Plea (49)
  • Task Forces/Task Force Officers (45)
  • Arrests/Convictions - Major (43)
  • Major Law Enforcement Operation (34)
  • Outreach/Drug Prevention (21)
  • HIDTA (13)
  • Press Conferences (13)
  • Gangs (10)
  • Diversion Division (8)
  • Pharmaceuticals/Pharmacists/Physicians (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Narcoterrorism (6)
  • Fentanyl Awareness (5)
  • Money Laundering (5)
  • Dark Web- Internet Trafficking (4)
  • One Pill Can Kill (3)
  • Extraditions (2)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Asset Forfeiture (1)
  • Critical Incident (1)
  • Prescription Drugs (13)

Drug Name

  • Oxycodone (19)
  • Opioids (18)
  • Hydromorphone (10)
  • Synthetic Opioids (6)
  • Benzodiazepines (4)
  • Amphetamines (3)
  • Cocaine (3)
  • Heroin (2)
  • Methadone (2)
  • Methamphetamine (2)
  • Morphine (2)
  • Steroids (2)
  • Marijuana (Cannabis) (1)
  • Fentanyl (13)

Field Division

  • Washington, DC (5)
  • Dallas (2)
  • St. Louis (2)
  • Houston (1)
  • New England (1)
  • New York (1)
  • Seattle (1)
Clear All Results
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

Diciembre 07, 2022
BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
Diciembre 07, 2022
PRESS RELEASE

DEA Washington Division Hosts 1st Family Summit to Engage with Families Affected by Fentanyl Poisoning

Noviembre 22, 2022
WASHINGTON, DC – The Drug Enforcement Administration (DEA) hosted regional family summits across the country in support of those who have lost loved ones to fentanyl poisoning. This is the first undertaking of its kind for the DEA field divisions and builds off the momentum of this summer’s Inaugural Family...
Noviembre 22, 2022
PRESS RELEASE

Nurse at St. Louis County Hospital Admits Fraudulently Obtaining Fentanyl

Octubre 27, 2022
ST. LOUIS – A nurse at a St. Louis County, Missouri, hospital pleaded guilty to a federal felony Thursday and admitted fraudulently obtaining fentanyl for her own personal use. Lindsay J. Maupin, 31, of Cape Girardeau, pleaded guilty in front of U.S. District Judge Stephen R. Clark to one felony...
Octubre 27, 2022
PRESS RELEASE

Physician Sentenced after Taking Bribes from Drug Manufacturer

Septiembre 13, 2022
SPRINGFIELD, Mo. – A Nixa, Mo., physician was sentenced in federal court today after taking bribes from a drug manufacturer in exchange for prescribing its fentanyl drug to his patients so often that he ranked highest in the state in net sales of the product. Randall Halley, 65, was sentenced...
Septiembre 13, 2022
PRESS RELEASE

Oklahoma City Hospital Pays $120,000 to Settle Civil Penalty Claims

Julio 19, 2022
OKLAHOMA CITY, OK – INTEGRIS ProHealth, Inc., and its parent, INTEGRIS Health, Inc. (collectively, “INTEGRIS”) paid $120,000 to settle civil penalty claims stemming from allegations that Integris Baptist Medical Center Pharmacy (“Integris Pharmacy”), which is owned and operated by INTEGRIS ProHealth, Inc., violated the Comprehensive Drug Abuse Prevention and Control...
Julio 19, 2022
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

Junio 08, 2022
ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
Junio 08, 2022
PRESS RELEASE

Montgomery County Drug Dealer Pleads Guilty to Distribution of Fentanyl that Led to an Overdose Death

Mayo 06, 2022
Greenbelt, Md – Enitan Mouroukeji Agbi, a/k/a “Anton Agbi,” and “Tone,” age 38, of Germantown, Maryland, pleaded guilty yesterday to distribution of fentanyl. Agbi admitted that Victim 1 died as a result of using drugs that Agbi distributed. The guilty plea was announced by Jarod Forget, Special Agent in Charge...
Mayo 06, 2022
PRESS RELEASE

Richland Physician Sentenced for Conspiring to Distribute Medically Unnecessary Fentanyl Patches, Opioid Pills and Other Controlled Substances

Abril 28, 2022
SPOKANE, Wash. – Senior U.S. District Judge Edward F. Shea has sentenced Dr. Janet Sue Arnold, age 63, of Benton City, Washington, to 48 months in federal prison for conspiring to distribute and possess with intent to distribute opioid pain medications and other controlled substances without a legitimate medical purpose...
Abril 28, 2022
PRESS RELEASE

Alexandria Man Sentenced for Armed Fentanyl Distribution Conspiracy

Marzo 04, 2022
ALEXANDRIA, Va. – An Alexandria man was sentenced today to 14 years in prison for conspiracy, possession, and distribution of fentanyl and Eutylone, and being a felon in possession of a firearm during drug trafficking. According to court documents, from in or around June 2020, through at least December 2020...
Marzo 04, 2022
PRESS RELEASE

Former Nurse at Danville Hospital Sentenced for Tampering with Prescription Opioid Drugs, Making False Statements

Marzo 04, 2022
DANVILLE, Va. – A former registered nurse working at Sovah Health-Danville was sentenced today to 36 months in federal prison for tampering with consumer products (fentanyl and hydromorphone) and making false statements. Emilee Kathryn Poteat, 31, pleaded guilty in May 2021 to one count of tampering with consumer products (fentanyl...
Marzo 04, 2022
Showing 1 - 10 of 13 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster